2019EndoscopyRequires access

ENDOSCOPIC PYLOROMYOTOMY (G-POEM), EFFICACITY EVALUATION AFTER ONE YEAR, IN REFRACTORY GASTROPARESIS: A FRENCH MULTICENTRIC STUDY

Olivier Ragi, Jérémie Jacques, Julien Branche, Serge Leblanc, G. Vanbiervliet, Romain Legros, Mathieu Pioche, Jérôme Rivory, Stanislas Chaussade, Véronique Vitton, Marc Barthet, JM González

Open publisher page 0 citations

Abstract

Aims: Long term results of G-POEM for refractory gastroparesis are lacking. Here we report the results of the largest multicenter study with long term follow up about G-POEM for refractory gastroparesis. Methods: Retrospective, multicentric study of all G-POEM cases, performed in six French expert centers, for refractory gastroparesis, within at least one year of follow up. Primary Endpoint: One year clinical success defined by improvement of GCSI by at least one point. Secondary Endpoints: complications rate, identification of predictors of clinical success, clinical success at two years. Results: Description of the population: 93 patients were included in 6 French expert centers. 65% were women, the medium age was 52 years old. About aetiologies: 31% diabetes, 25% post-surgery, 34% idiopathic and 8,5% systemic disease. The medium evolution duration of the symptoms was 73,5 months. The mean 4h% remaining in stomach before G-POEM, was 44,6%. The mean GCSI average before G-POEM was 3,6. Technical success was achieved in 96,1%. Primary Endpoint: Clinical success was achieved in 71% at 6 month, and 69% at one year, with an average decreasing GCSI score of 1,6 point. Secondary Endpoints : In multivariate analysis, only an high fullness underscore was significatively associated with an efficacity of the G-POEM (OR = 2,3 (1,35 – 3,88) p = 0,002). 18,3% of the patients declared pain after the therapeutic, controlled by paracetamol and PPI. 4,1% of the patients had complications, with a positive evolution under medical treatment. At two years clinical success was 69% (n = 39). Conclusions: This study confirms the efficiency and safety of G-POEM in the treatment of refractory gastroparesis The clinical success after one year is achieved for 69% of the patients. Only a high fullness subscale of the GCSI predicts efficiency. G-POEM should be the first treatment in case of refractory gastroparesis.

About this research paper

What this paper is about

Aims: Long term results of G-POEM for refractory gastroparesis are lacking. Here we report the results of the largest multicenter study with long term follow up about G-POEM for refractory gastroparesis. Methods: Retrospective, multicentric study of all G-POEM cases, performed in six French expert centers, for refractory gastroparesis, within at least one year of follow up. Primary Endpoint: One year clinical success defined by improvement of GCSI by at least one point. Secondary Endpoints: complications rate, identification of predictors of clinical success, clinical success at two years. Results: Description of the population: 93 patients were included in 6 French expert centers. 65% were women, the medium age was 52 years old. About aetiologies: 31% diabetes, 25% post-surgery, 34% idiopathic and 8,5% systemic disease. The medium evolution duration of the symptoms was 73,5 months. The mean 4h% remaining in stomach before G-POEM, was 44,6%. The mean GCSI average before G-POEM was 3,6. Technical success was achieved in 96,1%. Primary Endpoint: Clinical success was achieved in 71% at 6 month, and 69% at one year, with an average decreasing GCSI score of 1,6 point. Secondary Endpoints : In multivariate analysis, only an high fullness underscore was significatively associated with an efficacity of the G-POEM (OR = 2,3 (1,35 – 3,88) p = 0,002). 18,3% of the patients declared pain after the therapeutic, controlled by paracetamol and PPI. 4,1% of the patients had complications, with a positive evolution under medical treatment. At two years clinical success was 69% (n = 39). Conclusions: This study confirms the efficiency and safety of G-POEM in the treatment of refractory gastroparesis The clinical success after one year is achieved for 69% of the patients. Only a high fullness subscale of the GCSI predicts efficiency. G-POEM should be the first treatment in case of refractory gastroparesis.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Aims: Long term results of G-POEM for refractory gastroparesis are lacking. Here we report the results of the largest multicenter study with long term follow up about G-POEM for refractory gastroparesis. Methods: Retrospective, multicentric study of all G-POEM cases, performed in six French expert centers, for refractory gastroparesis, within at least one year of follow up. Primary Endpoint: One year clinical success defined by improvement of GCSI by at least one point. Secondary Endpoints: complications rate, identification of predictors of clinical success, clinical success at two years. Results: Description of the population: 93 patients were included in 6 French expert centers. 65% were women, the medium age was 52 years old. About aetiologies: 31% diabetes, 25% post-surgery, 34% idiopathic and 8,5% systemic disease. The medium evolution duration of the symptoms was 73,5 months. The mean 4h% remaining in stomach before G-POEM, was 44,6%. The mean GCSI average before G-POEM was 3,6. Technical success was achieved in 96,1%. Primary Endpoint: Clinical success was achieved in 71% at 6 month, and 69% at one year, with an average decreasing GCSI score of 1,6 point. Secondary Endpoints : In multivariate analysis, only an high fullness underscore was significatively associated with an efficacity of the G-POEM (OR = 2,3 (1,35 – 3,88) p = 0,002). 18,3% of the patients declared pain after the therapeutic, controlled by paracetamol and PPI. 4,1% of the patients had complications, with a positive evolution under medical treatment. At two years clinical success was 69% (n = 39). Conclusions: This study confirms the efficiency and safety of G-POEM in the treatment of refractory gastroparesis The clinical success after one year is achieved for 69% of the patients. Only a high fullness subscale of the GCSI predicts efficiency. G-POEM should be the first treatment in case of refractory gastroparesis.

Key concepts: Gastroparesis, Medicine, Refractory (planetary science), Pyloromyotomy, General surgery, Surgery, Gastroenterology, Stomach

Related papers

Back to paper searchBrowse research topicsOriginal source
ENDOSCOPIC PYLOROMYOTOMY (G-POEM), EFFICACITY EVALUATION AFTER ONE YEAR, IN REFRACTORY GASTROPARESIS: A FRENCH MULTICENTRIC STUDY — Research Paper | ScholarLens